Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation

Nephrology Dialysis Transplantation

Volumn 24, Issue 7, 2009, Pages 2244-2251

  Kozik Jaromin, Justyna ^a   Nier, Volker ^a   Heemann, Uwe ^b   Kreymann, Bernhard ^b   Böhler, Joachim ^c  

^a FRESENIUS MEDICAL CARE   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Calcium; Citrate; Dialysis; Pharmacokinetics; Regional anticoagulation

Indexed keywords

CALCIUM; CALCIUM CHLORIDE; CITRATE SODIUM; CITRIC ACID;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CALCIUM BALANCE; CLINICAL ARTICLE; DIALYSATE; DIALYSIS MEMBRANE; DISTRIBUTION VOLUME; DRUG HALF LIFE; DRUG INFUSION; DRUG METABOLISM; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPOCALCEMIA; KIDNEY FAILURE; MALE; MONITORING; PRIORITY JOURNAL; SAFETY; SUBSTITUTION THERAPY;

AGED; ANTICOAGULANTS; CALCIUM CHLORIDE; CITRATES; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 67651092320     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp017     Document Type: Article

References (26)

1. Hirsh J, Raschke R, Warkentin TE et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995; 108: 258S-275S
2. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983; 308: 258-261
3. Charney D, Salmond R. Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis. ASAIO Trans 1990; 36: M217-M219
4. Meier-Kriesche HU, Finkel KW, Gitomer JJ et al. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999; 33: e8
5. Whitfield LR, Levy G. Permeability of human and rat red blood cells to citrate. Thromb Res 1981; 21: 681-684
6. Werynski A. Evaluation of the impact of ultrafiltration on dialyzer clearance. Artif Organs 1979; 3: 140-142
7. Sargent J, Gotch F. Principles and Biophysics of Dialysis. In: Jacobs C, Kjellstrand C, Koch K, Winchester J (eds). Replacement of Renal Function by Dialysis. Dordrecht: Kluwer, 1996, 34-102
8. Nordmann J, Nordmann R. Organic acids in blood and urine. Adv Clin Chem 1961; 4: 53-120
9. Flanigan MJ, Von Brecht J, Freeman RM et al. Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation. Am J Kidney Dis 1987; 9: 147-153
10. Monchi M, Berghmans D, Ledoux D et al. Citrate versus heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004; 30: 260-265
11. Hofbauer R, Moser D, Frass M et al. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999; 56: 1578-1583
12. Bohler J, Schollmeyer P, Dressel B et al. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996; 7: 234-241
13. Clark JA, Schulman G, Golper TA. Safety and efficacy of regional citrate anticoagulation during 8-h sustained low-efficiency dialysis. Clin J Am Soc Nephrol 2008; 3: 736-742
14. Bunker JP, Bendixen HH, Murphy AJ. Hemodynamic effects of intravenously administered sodium citrate. N Engl J Med 1962; 266: 372-377
15. Hester JP, McCullough J, Mishler JM et al. Dosage regimens for citrate anticoagulants. J Clin Apheresis 1983; 1: 149-157
16. Bolan CD, Cecco SA, Wesley RA et al. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion 2002; 42: 935-946
17. Bolan CD, Greer SE, Cecco SA et al. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001; 41: 1165-1171
18. Janssen MJFM, Huijgens PC, Bouman AA et al. Citrate versus heparin anticoagulation in chronic haemodialysis patients. Nephrol Dial Transplant 1993; 8: 1228-1233
19. Apsner R, Schwarzenhofer M, Derfler K et al. Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 1997; 109: 123-127
20. Kramer L, Bauer E, Joukhadar C et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003; 31: 2450-2455
21. Bauer E, Derfler K, Joukhadar C et al. Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis 2005; 46: 903-907
22. Marx J, Bourdeau J. Calcium metabolism. In: Maxwell M, Kleeman C, Narins R (eds). Clinical Disorders of Fluid and Electrolyte Metabolism. New York: Mcgraw-Hill, 1987, 207-317
23. Hocken AG, Hurst PL. Citrate regional anticoagulation in haemodialysis. Nephron 1987; 46: 7-10
24. Faber LM, de Vries PM, Oe PL et al. Citrate haemodialysis. Neth J Med 1990; 37: 219-224
25. Dhondt A, Vanholder R, Waterloos MA et al. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules. Nephrol Dial Transplant 1998; 13: 1752-1758
26. Morath C, Miftari N, Dikow R et al. Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrol Dial Transplant 2008; 23: 421-422